| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cell Biology, Institute of Biology, State University of Campinas (UNICAMP), Campinas SP, Brazil.
| Correspondence to: Hernandes F. Carvalho, Department of Cell Biology, UNICAMP, CP6109, 13083-863 Campinas SP, Brazil (e-mail: hern{at}unicamp.br). |
| Received for publication March 26, 2007; accepted for publication May 21, 2007. |
| Abstract |
|---|
|
|
|---|
-actin and SM-myosin heavy chain [MHC]),
transmission electron microscopy (TEM), and reverse transcription polymerase
chain reaction (smoothelin, sm22, and calponin). The prostates of castrated
rats showed significant weight reduction, corresponding to only 5.6% of the
control. Stereology showed that SMCs occupied the same proportion of the
prostate volume but suffered a significant reduction in absolute volume (5.5%
of control). The SMCs were retracted and showed spinous outlines. TEM revealed
the presence of an abundant myofibrillar component, dense plaques, and an
external lamina in these cells. SMCs were reactive to antibodies against SM
-actin and SM-MHC and expressed mRNA for smoothelin, sm22, and
calponin. The results confirmed that rat prostatic SMCs are affected by
androgen deprivation. Although showing marked phenotypic changes, these cells
expressed SMC markers at the protein (SM
-actin and SM-MHC) and mRNA
(smoothelin, sm22, and calponin) levels. These observations support the idea
that SMCs may modulate their phenotypes (contractile vs synthetic) without
changing their differentiation states.
Key words: Calponin, myosin heavy chain, sm22, smoothelin
More recently new markers have been proposed to be specific for SMCs (Doevendans and van Eys, 2002). Using some of these markers, we showed that, in addition to extensive morphologic changes including an increase in the volume density of organelles of the synthetic secretory pathway (Vilamaior et al, 2005), SMCs exhibit many of the morphologic landmarks of differentiated cells and preserve SM myosin heavy chain (MHC) and smoothelin expression up to 21 days after castration (Antonioli et al, 2004). This finding led us to propose that the contractile to synthetic phenotypic change does not involve dedifferentiation.
We further argued that the discrepancy between our results and those
reported by Hayward et al
(1996) might be attributable to
the length of the androgen deprivation period (21 vs 100 days, respectively)
and/or the use of distinct differentiation markers (myosin, vinculin, desmin,
and laminin vs smoothelin and MHC) and then decided to investigate whether
long-term castration results in the loss of these newer and more specific
markers of SMC differentiation. Pursuing this task, we investigated the
expression of SM
-actin and SM-MHC (at the protein level) and
smoothelin, sm22, and calponin (at the mRNA level), as well as morphologic,
ultrastructural, and stereologic alterations, to determine the effects of
long-term androgen deprivation on the differentiation state of SMCs in the rat
ventral prostate. The results allowed us to confirm that, despite showing
morphologic changes, SMCs preserve their differentiated state after long-term
castration.
| Materials and Methods |
|---|
|
|
|---|
The ventral prostates were dissected out, weighed, and immediately fixed by immersion in 4% formaldehyde in phosphate-buffered saline for 24 hours. The samples were then washed, dehydrated, cleared in xylene, and embedded in Paraplast Plus embedding medium (Oxford Labware, St Louis, Mo) for immunocytochemistry. Some fragments were partially dehydrated and embedded in Historesin (Leica Microsystems, Heidelberg, Germany) for general morphology. Stereology was performed as described previously (Antonioli et al, 2004; Garcia-Florez et al, 2005). Volume density (Vv) was calculated as the percent of points in Weibel grid falling on SMC. The total SMC volume was calculated as a product of volume density per prostatic weight, considering the specific gravity of the prostatic tissue as 1.0 (Huttunen et al, 1981). The results were compared using the Student's 2-sample t-test.
Transmission Electron Microscopy![]()
Tissue fragments (
1 mm3) were processed for transmission
electron microscopy. In brief, the fragments were fixed for 24 hours in a
solution containing 0.25% tannic acid and 3% glutaraldehyde in Millonig
buffer, postfixed in 1% osmium tetroxide for 1 hour, and then incubated in
0.5% uranyl acetate in maleate buffer overnight before dehydration in a graded
acetone series and embedding in Araldite (Polysciences Inc, Warrington, Pa).
Ultrathin sections were contrasted with lead citrate. Analysis and
documentation were carried out with a Leo 906 transmission electron microscope
(Zeiss, Oberkochen, Germany).
Immunocytochemistry![]()
Five-micrometer sections were mounted on silanized glass slides, dewaxed
with xylene, and rehydrated in a decreasing ethanol series. Endogenous
peroxidase activity was blocked with 3% hydrogen peroxide in water for 30
minutes. Nonspecific protein-protein interactions were blocked by incubation
with 3% bovine serum albumin (BSA; Sigma-Aldrich, St Louis, Mo) in
Tris-buffered saline containing 0.1% Tween 20 (TBS-T) for 1 hour. Monoclonal
antibodies against SM
-actin (A2547; Sigma-Aldrich) and SM-MHC
(sc-6956; Santa Cruz Biotechnology, Santa Cruz, Calif) were diluted 1:50 and
1:100, respectively, in TBS-T containing 1% BSA and applied to sections for 1
hour at room temperature. After three 5-minute washes with TBS-T, the sections
were incubated with a peroxidase-conjugated antibody against mouse polyvalent
immunoglobulins (Sigma-Aldrich) diluted 1:100 in 1% BSA in TBS-T for 1 hour.
Sections were washed again, and peroxidase activity was developed with
3,3'-diaminobenzidine followed by counterstaining with methyl green, air
drying, and mounting in Entellan (Merck, Darmstadt, Germany). For SM-MHC
immunocytochemistry, sections were pretreated with 0.4% pepsin in 0.01 N HCl
for 30 minutes at 37°C before endogenous peroxidase blocking. The
specimens were observed under a Zeiss Axioskop microscope and photographed
using Kodak 100 Proimage film (Rochester, NY).
Reverse Transcription Polymerase Chain Reaction![]()
The prostates were dissected out, weighed, and immediately homogenized with
a Polytron in TRIzol (Invitrogen, Carlsbad, Calif). Total RNA was then
extracted according to the instructions provided by the manufacturer. The
amount of RNA was determined by measuring the absorbances at 260 and 280 nm
using a correspondence factor of 40. For cDNA synthesis, reverse transcription
(RT) was performed using SuperScript III reverse transcriptase (Invitrogen)
for 60 minutes at 50°C and for 15 minutes at 70°C. Polymerase chain
reaction (PCR) was carried out with 150 ng of cDNA in a final volume of 25
µL containing Taq polymerase PCR master mix (Promega Corporation, Madison,
Wis) and 0.6 pmol of the following primer sets (Invitrogen) under the
following reaction conditions: ß-actin forward
5'-CTGGCCTCACTGTCCACCTT-3', reverse
5'-AGTACGATGAGTCCGGCCC-3', annealing temperature 64°C, 30
cycles; smoothelin forward 5'-GTCGACATCCAGAACTTCCTCC-3', reverse
5'-CGCAGGTGGTTGTACAGCGA-3', annealing temperature 94°C, 35
cycles (Rensen et al, 2002);
calponin forward 5'-GAAGATCAATGAGTCAACCG-3', reverse
5'-TGTTCTCAAACAGGTCGTTGGC-3', annealing temperature 61.5°C, 30
cycles; and sm22 forward 5'-AGGTCTGGCTGAAGAATGGC-3', reverse
5'-TTCAAAGAGGTCAACAGTCTGG-3', annealing temperature 60°C, 30
cycles. The sizes of the reaction products for ß-actin, smoothelin,
calponin, and sm22 were 64, 440 (visceral) and 330 (vascular), 150, and 200
bp, respectively. PCR products were analyzed by 2% agarose gel electrophoresis
in Tris-acetate-EDTA buffer and visualized by ethidium bromide staining. The
50-bp DNA step ladder (Promega Corporation) was used as a marker.
| Results |
|---|
|
|
|---|
|
Androgen deprivation resulted in marked remodeling of the rat ventral prostate. In addition to marked epithelial modifications, hematoxylin and eosin staining revealed that control SMCs were elongated and flattened against the epithelial basement membrane, showing slightly irregular outlines. Following castration, shortening of the cell was observed accompanied by a pleating of the cell surface, leading to a spinous aspect (Figure 1A and B). The SMCs apparently lost the contact between each other and presented with wider extracellular spaces. Usually more than 1 layer of SMCs was found below the epithelial structures after castration.
|
Stereologic analysis showed that androgen deprivation for 100 days did not result in any modification of the prostatic volumetric fraction (Vv) occupied by SMCs (Table 2). However, considering the large reduction in prostatic weight, long-term castration caused a significant decrease in absolute SMC volume (ie, SMC volume corresponded to only 5.5% of that calculated for the age-matched control) (Table 2).
|
|
|
In addition to the morphologic and ultrastructural characterization of the
effects of long-term androgen deprivation, we also investigated the expression
of some SMC markers. Immunocytochemistry revealed that SM
-actin
(Figure 1C through E) and
SM-MHC (Figure 1F through H)
were present in the SMCs of control rats
(Figure 1C and F, respectively)
and that androgen deprivation for 100 days had no effect on this expression
pattern (Figure 1D and E, and 1G and
H, respectively). Moreover, RT-PCR showed that smoothelin,
calponin, and sm22 were expressed at the mRNA level in the ventral prostate of
control and castrated rats (Figure
3). The expression of the visceral isoform of smoothelin
(Figure 3B) was identified.
| Discussion |
|---|
|
|
|---|
Vascular SMCs have received more attention than the prostatic ones. However, prostatic SMCs are also important because of their central role in benign prostatic hyperplasia (Shapiro et al, 1992) and because they seem to be important in regulating epithelial function and behavior, including in cancer (Cunha et al, 1996; Hayward and Cunha, 2000). The primary response of prostatic SMCs to castration is related to the fact that they express the androgen receptor (Prins et al, 1991; Hayward and Cunha, 2000).
We previously examined the behavior of prostatic SMCs in castrated rats and
observed that these cells undergo extensive morphologic changes
(Antonioli et al, 2004) and
present an increase in secretory organelles
(Vilamaior et al, 2005) after
androgen deprivation for 21 days. We also showed that these cells express SM
-actin, MHC, and smoothelin
(Antonioli et al, 2004),
suggesting that these cells undergo marked phenotypic modifications in
association with distinct functions
(Vilamaior et al, 2000) but
preserve their differentiation states. This assumption is in perfect agreement
with the idea of Owens et al
(2004) on vascular SMC
phenotype modulation (or switching). On the other hand, this proposal
contradicts a previous report by Hayward et al
(1996), who studied the
differentiation of SM during prostatic development as well as changes related
to androgen deprivation and concluded that the modifications reported for the
latter reproduced the developmental acquisition of differentiation markers.
This discrepancy might be attributed to the use of different differentiation
markers, as well as to the investigation of different periods of androgen
deprivation.
The present study was then idealized to reproduce the long-term castration
experiment of Hayward et al
(1996) using the same markers
as employed before (Antonioli et al,
2004), in addition to a detailed morphologic study of SMCs. We
showed that SMCs occupy a volume twice that of the prostate in these aged
animals as compared with 90-day-old animals
(Antonioli et al, 2004) and
that they became markedly atrophic after 100 days of androgen deprivation.
Although SMCs occupied the same volume fraction of the organ (
10%) with
respect to the age-matched controls, they showed a marked reduction in the
total volume, considering the extreme reduction in prostatic weight. At the
ultrastructural level, SMCs were readily recognized by the presence of
abundant myofilaments, external lamina (basal lamina) and subplasmalemmal
dense plaques. These cells were also reactive to anti–SM
-actin
and anti–SM-MHC, in addition to expressing smoothelin, sm22, and
calponin. While the last 2 markers might reflect the presence of vascular SM,
the expression of the visceral (or urogenital) isoform of smoothelin
(Rensen et al, 2002) is
probably restricted to prostatic SMCs.
It is possible that a fraction of the SMCs do indeed dedifferentiate and contribute to the reduction in the total SMC volume in the prostate of castrated animals, in addition to the death of some and the atrophy of the remaining differentiated cells. This question will require precise methods for labeling and counting SMCs for different periods after castration.
It is not well known to what extent prostatic SMCs are comparable to
vascular SMCs. However, it has been shown for the latter that the quiescent
(and contractile) state is due to the expression and activation of cAMP
response element–binding protein (CREB) and that the transition to a
proliferative and migratory phenotype involves CREB inactivation
(Reusch and Watson, 2004).
Other transcription factors probably involved in this transition are GATA6 and
GAX (favoring the quiescent state) and basic transcription
element–binding protein 2 and Egr-1 (favoring the proliferative state),
whereas serum response factor and myocyte enhancer factor 2 would have dual
effects on SMC behavior (Walsh and
Takahashi, 2001). Myocardin is another important factor regulating
the expression of SMC-specific molecules
(Owens et al, 2004).
Furthermore, the specific arrangement of CArG elements (CC[AT]6GG
motif) and their variations within the promoter region of genes encoding
sm22, MHC, and
-actin are likely to be responsible for setting
the cell type specificity and temporal expression of SMC-specific genes
(Owens et al, 2004). The
expression and function of these transcription factors have not been
investigated in prostatic SMCs and thus deserve future study.
Another important question in the biology of prostatic SMCs is whether the alterations in SMC phenotype observed after androgen deprivation are comparable to those seen in cancer invasion. Researchers have studied the modifications in SMC behavior during stromal activation in response to cancer progression and emphasized that SMCs undergo progressive dedifferentiation to myofibroblasts (Cunha et al, 1996; Tuxhorn et al, 2001, 2002; Wong and Tam, 2002). Whereas the use of cell cultures is of limited applicability since the mere placement of SMCs in culture is sufficient to promote phenotypic changes, the lack of appropriate experimental models limits the progress in this area.
In conclusion, we demonstrated that prostatic SMCs undergo phenotypic modulation (or switching) upon androgen deprivation while preserving major differentiation markers. It should be emphasized that the phenotypic modulation of SMCs upon androgen deprivation cannot be seen as a passive response but should be considered to be an active adaptation to the new hormonal condition as well as to the changing stromal (and organ) microenvironment, with possible contributions of altered levels of transforming growth factor ß and basic fibroblast growth factor (Niu et al, 2003).
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Boesch ST, Corvin S, Zhang J, Rogastsch H, Bartsch G, Klocker H.
Modulation of the differentiation status of cultured prostatic smooth muscle
cells by an
1-adrenergic receptor antagonist.
Prostate. 1999;39: 226
-233.[CrossRef][Medline]
Carvalho HF, Line SRP. Basement membrane associated changes in the rat ventral prostate following castration. Cell Biol Int. 1996;20: 809 -819.[CrossRef][Medline]
Carvalho HF, Vilamaior PS, Taboga SR. Elastic system of the rat ventral prostate and its modifications following orchiectomy. Prostate. 1997;32: 27 -34.[Medline]
Cunha GR, Hayward SW, Dahiya R, Foster BA. Smooth muscleepithelial interactions in normal and neoplastic prostatic development. Acta Anat. 1996;155: 63 -72.[Medline]
Doevendans PA, van Eys G. Smooth muscle cells on the move: the
battle for actin. Cardiovasc Res. 2002; 54: 499
-502.
Garcia-Florez M, Oliveira CA, Carvalho HF. Early effects of estrogen on the rat ventral prostate. Braz J Med Biol Res. 2005;38: 487 -497.[Medline]
Gittenberger-de-Groot AC, DeRuiter MC, Bergwerff M, Poelmann RE.
Smooth muscle cell origin and its relation to heterogeneity in development and
disease. Arterioscler Thromb Vasc Biol. 1999; 19: 1589
-1594.
Hayward SW, Baskin LS, Haughney PC, Foster BA, Cunha AR, Dahiya R, Prins GS, Cunha GR. Stromal development in the ventral prostate, anterior prostate and seminal vesicle of the rat. Acta Anat. 1996; 155: 94 -103.[Medline]
Hayward SW, Cunha GR. The prostate: development and physiology. Radiol Clin North Am. 2000; 38: 1 -14.[CrossRef][Medline]
Huttunen E, Romppanen T, Helminen HJ. Testosterone action on the ventral prostate lobe of the castrated rat as assessed with a stereologic morphometric method. Am J Anat. 1981; 165: 199 -209.[CrossRef]
Isaacs JT, Furuya Y, Berges R. The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue. Semin Cancer Biol. 1994; 5: 391 -400.[Medline]
Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, Sun G. Androgen and prostatic stroma. Asian Androl. 2003; 5: 19 -26.
Niu Y, Xu Y, Zhang J, Bai J, Yang H, Ma T. Proliferation and differentiation of prostatic stromal cells. BJU Int. 2001; 87: 386 -393.[CrossRef][Medline]
Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular
smooth muscle cell differentiation in development and disease.
Physiol Rev. 2004; 84: 767
-801.
Prins GS, Birch L, Greene GL. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology. 1991; 129: 3187 -3199.[Abstract]
Rensen SSM, Thijssen VLJL, DeVries C, Doevendans P, Detera-Wadleigh
S, van Eys G. Expression of the smoothelin gene is mediated by alternative
promoters. Cardiovasc Res. 2002; 55: 850
-863.
Reusch JEB, Watson PA. Loss of CREB regulation of vascular smooth muscle cell quiescence in diabetes. Rev Endocr Metabol Dis. 2004;5: 209 -219.[CrossRef]
Shabsigh A, Chang DT, Heitjan DF, Kiss A, Olsson CA, Puchner PJ, Buttyan R. Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival. Prostate. 1998; 36: 201 -206.[CrossRef][Medline]
Shabisgh A, Tanji N, D'Agati V, Burchardt M, Rubin M, Goluboff ET,
Heitjan D, Kiss A, Buttyan R. Early effects of castration on the vascular
system of the rat ventral prostate gland.
Endocrinology. 1999; 140: 1920
-1926.
Shapiro E, Hartanto V, Becich MJ, Lepor H. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic BPH. J Urol. 1992; 147: 1293 -1297.[Medline]
Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol. 2001; 166: 2472 -2483.[CrossRef][Medline]
Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR.
Reactive stroma in human prostate cancer: induction of myofibroblast phenotype
and extracellular matrix remodeling. Clin Cancer Res. 2002; 8: 2912
-2923.
Vilamaior PSL, Felisbino SL, Taboga SR, Carvalho HF. Collagen fiber reorganization in the rat ventral prostate following androgen deprivation: a possible role for the smooth muscle cells. Prostate. 2000; 45: 253 -258.[CrossRef][Medline]
Vilamaior PSL, Taboga SR, Carvalho HF. Modulation of smooth muscle cell function: morphological evidence for a contractile to synthetic transition in the rat ventral prostate after castration. Cell Biol Int. 2005;29: 809 -816.[CrossRef][Medline]
Walsh K, Takahashi A. Transcriptional regulation of vascular smooth muscle cell phenotype [in German]. Z Kardiol. 2001; 90(Suppl 3): 12 -16.[CrossRef][Medline]
Wong YC, Tam NNC. Dedifferentiation of stromal smooth muscle as a factor in prostate carcinogenesis. Differentiation. 2002; 70: 633 -645.[CrossRef][Medline]
Zhao GQ, Holterhus PM, Dammshaüser I, Hoffbauer G, Aumüller G. Estrogen-induced morphological and immunohistochemical changes in stroma and epithelium of rat ventral prostate. Prostate. 1992;21: 183 -199.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |